
Citation: Kochar Khasro Saleh, Semih Dalkiliç, Lütfiye Kadioğlu Dalkiliç, Bahra Radhaa Hamarashid, Sevda Kirbağ. Targeting cancer cells: from historic methods to modern chimeric antigen receptor (CAR) T-Cell strategies[J]. AIMS Allergy and Immunology, 2020, 4(2): 32-49. doi: 10.3934/Allergy.2020004
[1] | Simone Fiori . Coordinate-free Lie-group-based modeling and simulation of a submersible vehicle. AIMS Mathematics, 2024, 9(4): 10157-10184. doi: 10.3934/math.2024497 |
[2] | Imran Siddique, Yasir Khan, Muhammad Nadeem, Jan Awrejcewicz, Muhammad Bilal . Significance of heat transfer for second-grade fuzzy hybrid nanofluid flow over a stretching/shrinking Riga wedge. AIMS Mathematics, 2023, 8(1): 295-316. doi: 10.3934/math.2023014 |
[3] | Umair Khan, Aurang Zaib, Sakhinah Abu Bakar, Anuar Ishak, Dumitru Baleanu, El-Sayed M Sherif . Computational simulation of cross-flow of Williamson fluid over a porous shrinking/stretching surface comprising hybrid nanofluid and thermal radiation. AIMS Mathematics, 2022, 7(4): 6489-6515. doi: 10.3934/math.2022362 |
[4] | H. Thameem Basha, R. Sivaraj, A. Subramanyam Reddy, Ali J. Chamkha, H. M. Baskonus . A numerical study of the ferromagnetic flow of Carreau nanofluid over a wedge, plate and stagnation point with a magnetic dipole. AIMS Mathematics, 2020, 5(5): 4197-4219. doi: 10.3934/math.2020268 |
[5] | Sami Ul Haq, Saeed Ullah Jan, Syed Inayat Ali Shah, Ilyas Khan, Jagdev Singh . Heat and mass transfer of fractional second grade fluid with slippage and ramped wall temperature using Caputo-Fabrizio fractional derivative approach. AIMS Mathematics, 2020, 5(4): 3056-3088. doi: 10.3934/math.2020198 |
[6] | Zehba Raizah, Arshad Khan, Saadat Hussain Awan, Anwar Saeed, Ahmed M. Galal, Wajaree Weera . Time-dependent fractional second-grade fluid flow through a channel influenced by unsteady motion of a bottom plate. AIMS Mathematics, 2023, 8(1): 423-446. doi: 10.3934/math.2023020 |
[7] | Muhammad Amin Sadiq Murad, Faraidun Kadir Hamasalh, Hajar F. Ismael . Numerical study of stagnation point flow of Casson-Carreau fluid over a continuous moving sheet. AIMS Mathematics, 2023, 8(3): 7005-7020. doi: 10.3934/math.2023353 |
[8] | A. Tomar, H. Kumar, M. Ali, H. Gandhi, D. Singh, G. Pathak . Application of symmetry analysis and conservation laws to a fractional-order nonlinear conduction-diffusion model. AIMS Mathematics, 2024, 9(7): 17154-17170. doi: 10.3934/math.2024833 |
[9] | Khalil Ur Rehman, Wasfi Shatanawi, Zead Mustafa . Artificial intelligence (AI) based neural networks for a magnetized surface subject to tangent hyperbolic fluid flow with multiple slip boundary conditions. AIMS Mathematics, 2024, 9(2): 4707-4728. doi: 10.3934/math.2024227 |
[10] | Yang Pan, Yanyong Hong . Varieties of a class of elementary subalgebras. AIMS Mathematics, 2022, 7(2): 2084-2101. doi: 10.3934/math.2022119 |
Stagnation point flow reveals in practically all flow branches of engineering and science. Free stagnation point or a line exists interior of the fluid domain while in some situations flow is stagnated by a solid wall.
Hiemenz [1] demonstrated that Navier-Stokes equations are able to describe the stagnation point flow. Plane stagnation point flow which is called the Hiemenz flow, firstly discussed by Hiemenz as follows:
f‴+ff″−(f′)2+1=0, | (1.1) |
with the boundaries:
f(0)=0, f′(0)=0, f′(∞)=1. | (1.2) |
Gersten et al. [2] generalized these results to the stagnation point flow in three dimensions. Homotopy analysis method is used by Liao [3] to the 2D laminar viscous flow over a semi-infinite plate. Existence and uniqueness consequences for nonlinear third-order ODEs appeared in the stagnation point flow of a hydromagnetic fluid are discussed by Van Gorder et al. [4]. The flow characteristics in an electrically conducting second grade fluid pervaded by a uniform magnetic field over a stretching sheet is discussed by Vajravelu et al. [5]. Steady 2D stagnation-point flow of an incompressible viscous electrically conducting fluid over a flat deformable sheet is studied by Mahapatra et al. [6]. Van Gorder et al. [7] established the existence and uniqueness consequences for fourth-order ODEs over the semi-infinite interval, arising in the hydromagnetic stagnation point flow of a second grade fluid over a stretching sheet.
The concept of Lie groups plays an significant rule in establishing some intense numerical approaches to integrate ODEs, which conserve the geometrical properties. Preserving the geometry construction under discretization, is essential in the improvement of a qualitatively true performance in the minimization of approximation errors. So, along with the geometric structure and invariance of the ODEs, novel approaches may be invented, which are more stable and effective than the common approximation techniques.
A novel geometric method based on GL(6,R) is introduced for the magneto-hemodynamic flow in a semi-porous channel in [8]. Moreover, in [9], a nonlinear heat transfer equation is considered by SL(2,R). Order of differential equations and different initial or boundary conditions conclude different geometric algorithms for solving differential equations. That is, numerical algorithms based on e.g. GL(6,R) and GL(4,R) is completely different. Combination of radial basis functions with GPS are discussed in [10]. Some other recent papers of geometric numerical approach, Lie group analysis, and exact solution can be found in [11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33].
This paper is organized as follows. In the further section, we will touch only a few aspects of the Mathematical formulation for the hydromagnetic stagnation point flow. In Section 3, we derive an interesting algorithm to integrate the underlying nonlinear equation. Section 4 deals with the numerical results. Final remarks are provided in the conclusion section.
Let us investigate the 2D steady stagnation-point flow of an electrically conducting fluid in the existence of a uniform transverse magnetic field towards a flat surface coinciding with the plane y=0, the flow being enclosed to the region y>0. Two equivalent and converse forces are considered in direction of the x−axis such that the wall is stretched keeping the origin fixed, and a uniform magnetic field B0 is forced along the y−axis (Figure 1).
In the usual notation, the MHD equations for steady 2D stagnation-point flow in the boundary layer along the stretching surface are [6,34]:
ux+vy=0, | (2.1) |
uux+vuy=UUx+νuyy+σB20ρ(U−u), | (2.2) |
where ρ, σ, B0 are density, electrical conductivity and magnetic field respectively. Also, (u,v) are the fluid velocity components toward x and y. U(x) stands for the stagnation-point velocity in the inviscid free stream.
For this problem, the boundaries are
u=cx, v=0, at y=0, | (2.3) |
u→U(x)=ax, as y→∞, | (2.4) |
where c,a∈R+. Eqs (2.1) and (2.2) together with the conditions (2.3) and (2.4) have the similarities of the form
u(x,y)=cxf′(ξ), v(x,y)=−√cνf(ξ), ξ=y√cν. | (2.5) |
Substituting (2.5) into (2.2), concludes
f‴(ξ)+f(ξ)f″(ξ)−(f′(ξ))2−Mf′(ξ)+C(C+M)=0, | (2.6) |
where M=B20(σρc), C=ac and √M is the Hartmann number.
With the use of the transformation (2.5), the boundary conditions (2.3) and (2.4) read f(0)=0, f′(0)=1, f′(∞)=C.
The self-similar solutions will normally be made to meet Eq (2.6) with additional nonlinear terms
K[2f′(ξ)f‴(ξ)−(f″(ξ))2−f(ξ)f(iv)(ξ)], | (2.7) |
in the governing differential equation, where K≥0 is the viscoelastic parameter. By the additional condition f″(∞)=0, we investigate the following fourth order differential equation:
f‴(ξ)+f(ξ)f″(ξ)−(f′(ξ))2−Mf′(ξ)+K[2f′(ξ)f‴(ξ)−(f″(ξ))2−f(ξ)f(iv)(ξ)]+C(C+M)=0, | (2.8) |
with
f(0)=s≥0, f′(0)=χ≥0, f′(∞)=C≥0, f″(∞)=0, | (2.9) |
where M=σ0B20/ρB≥0 is the magnetic parameter, K=ωB/ν≥0 is the viscoelastic parameter, s≥0, C is the parameter due to the stagnation point flow, and χ is the stretching of the sheet.
There is no loss of generality in assuming
f(ξ)>0 & f‴(ξ)>0, ∀ξ∈[0,∞). | (3.1) |
This supposition is possible. Because in the other case, we can obtain a constant γ>0 such that
F‴(ξ)=f‴(ξ)+γ>Max{0,Υ1,Υ2}, | (3.2) |
F″(ξ)=f″(ξ)+γξ+c1, | (3.3) |
F′(ξ)=f′(ξ)+γξ22+c1ξ+c2, | (3.4) |
F(ξ)=f(ξ)+γξ36+c1ξ22+c2ξ+c3, | (3.5) |
where
Υ1=min{|f(ξ)| :ξ∈[0,∞)}, Υ2=min{|f‴(ξ)| :ξ∈[0,∞)}, | (3.6) |
and c1-c3 are integration constants which we can assume all of them to be positive. Also, from this assumption we clearly have |F(ξ)|>0. Using these transformations, Eq (2.8) converts into:
F‴−γ+(F−γξ36−c1ξ22−c2ξ−c3)(F″−γξ−c1)−M(F′(ξ)−γξ22−c1ξ−c2)+K[2(F′(ξ)−γξ22−c1ξ−c2)(F‴−γ)−(F″−γξ−c1)2−F(iv)(F−γξ36−c1ξ22−c2ξ−c3)]+C(C+M)=0, |
subject to
F(0)=s+c3>0, F′(0)=χ+c2>0, F′(∞)→∞, F″(∞)→∞. |
Now, we are willing to erect GL(4,R) Lie group method. Suppose y1(ξ)=f(ξ), y2(ξ)=f′(ξ), y3(ξ)=f″(ξ) and y4(ξ)=f‴(ξ). Then equivalent system of (2.8) leaves
{y′1(ξ)=y2(ξ), y′2(ξ)=y3(ξ), y′3(ξ)=y4(ξ), y′4(ξ)=2y2y4−y23y1+y4+y1y3−y22−My2+C(C+M)Ky1, | (3.7) |
with boundary conditions:
y1(0)=y01=s, y2(0)=y02=χ, y2(∞)=yf2=C, y3(∞)=yf3=0. | (3.8) |
Equivalent system of (3.7) is:
ddξ(y1(ξ)y2(ξ)y3(ξ)y4(ξ))=(010000100001000Ω(ξ,y1,y2,y3,y4))(y1(ξ)y2(ξ)y3(ξ)y4(ξ)), | (3.9) |
where
Ω(ξ,y1,y2,y3,y4):=2y2y4−y23y1y4+y4+y1y3−y22−My2+C(C+M)Ky1y4, | (3.10) |
which is well-defined because of supposition (3.1). System (3.9), in spite of its nonlinearity, admits a Lie-group of GL(4,R) and we have:
ddξG=AG, G(0)=I4×4, | (3.11) |
where
A=(010000100001000Ω). | (3.12) |
Now, we are able to erect a GPS to consider Eq (3.9) as follows:
Yn+1=G(n)Yn, G(n)∈GL(4,R), | (3.13) |
where Yn=Y|ξ=ξn. Integrating (3.9) by (3.13) along with initial condition Y(0)=Y0, results the demanded value Y(ξ). Suppose the GPS method:
Yn+1=Yn+(αn−1)Fn.Yn+βn‖Yn‖‖Fn‖‖Fn‖2, | (3.14) |
where
αn=cosh(Δξ‖Fn‖‖Yn‖), βn=sinh(Δξ‖Fn‖‖Yn‖), | (3.15) |
and Δξ=1/N is the GPS iteration stepsize. In fact, this approach approximates the solution of
{Y′=F(ξ,Y),Y(0)=Y0. | (3.16) |
Then
Yf=GN(Δξ)⋯G1(Δξ)Y0, | (3.17) |
computes Y(ξ)|ξ=η∞, * at ξ=η∞. From the closure property of the Lie groups, G:=GN(Δξ)⋯G1(Δξ)∈GL(4,R). Therefore, we can develop a one-step transformation from Y0 to Yf as:
* By using the truncation rule for the differential equations over the infinite or semi-infinite intervals, we set ξf=η∞ as the final value of interval [0,∞).
Yf=GY0, G∈GL(4,R). | (3.18) |
From Eqs (3.11) and (3.18) we obtain
G(ξ)=exp(∫ξ0A(η)dη). | (3.19) |
Along with (3.8) and generalized mid-point rule, let us assume
ˆξ=rξ0+(1−r)ξf=(1−r)η∞,ˆy1=ry01+(1−r)yf1=rs+(1−r)yf1,ˆy2=ry02+(1−r)yf2=rχ+(1−r)C,ˆy3=ry03+(1−r)yf3=ry03,ˆy4=ry04+(1−r)yf4=ry04+(1−r)yf4, |
where r∈[0,1] has to be determined. Therefore Eq (3.19) may be rewritten as:
G(r)=exp(A(ˆξ,ˆy1,ˆy2,ˆy3,ˆy4)), | (3.20) |
where
A(ˆξ,ˆy1,ˆy2,ˆy3,ˆy4)=:(010000100001000ω), ω=Ω(ˆξ,ˆy1,ˆy2,ˆy3,ˆy4). | (3.21) |
In this letter, y01=s, y02=χ, yf2=C, yf3=0 are known and yf1, y03, y04, yf4 are unknown values of the current problem, which after determining y03 and y04, the B.V.P. (2.8) converts to an I.V.P.
For the fixed A∈gl(4,R), † we have
† gl(4,R) is the Lie algebra associated with the Lie group GL(4,R).
G(r)=(1η∞η2∞22eη∞ω−2η∞ω−(η∞ω)2−22ω301η∞eη∞ω−η∞ω−1ω2001eη∞ω−1ω000eη∞ω), | (3.22) |
where
ω=2ˆy2ˆy4−ˆy23ˆy1ˆy4+ˆy4+ˆy1ˆy3−ˆy22−Mˆy2+C(C+M)Kˆy1ˆy4. | (3.23) |
Therefore, each of this Lie group elements may be erected by a single parameter G(r), with r∈[0,1].
From (3.18) and (3.22) we have:
(yf1yf2yf3yf4)=(1η∞η2∞22eη∞ω−2η∞ω−(η∞ω)2−22ω301η∞eη∞ω−η∞ω−1ω2001eη∞ω−1ω000eη∞ω)(y01y02y03y04). | (3.24) |
Thus, for a given r, we may get the values yf1, y03, y04 and yf4 by the further explained process.
Imposing the initial guesses of y03, y04, yf1 and yf4, and the given boundary values of y01=s, y02=χ, yf2=C and y03=0, with a specified r∈[0,1], and from
{y03=ω(C−χ)(eη∞ω−1)(η∞ω−1)eη∞ω+1, y04=ω2(χ−C)(η∞ω−1)eη∞ω+1,yf1=eη∞ω(2sη∞ω2−2sω+χη2∞ω2−2χη∞ω+Cη2∞ω2−2C+2χ)+2sω+2Cη∞ω+2C−2χ2ω((η∞ω−1)eη∞ω+1),yf4=ω2(χ−C)eη∞ω(η∞ω−1)eη∞ω+1, | (3.25) |
we may produce new values of yf1, y03, y04 and yf4. If these values satisfy the convergence criterion:
√∑i∈{3,4}(y0iNew−y0iOld)2+∑i∈{1,4}(yfiNew−yfiOld)2≤ϵ, | (3.26) |
then iterations stop.
For a fixed value of r, we are able to compute y03 and y04 from Eq (3.25) and then approximately integrate Eq (3.7) by GPS from 0 to η∞, and compare the end value of yf2 and yf3 with the exact ones y2(η∞)=C and y3(η∞)=0 respectively. That is, we have to find the minimum value of
minr∈[0,1]√(yf2−C)2+(yf3)2. | (3.27) |
In the appendix, we give a brief algorithm of our proposed method to find the initial values of problem.
In the non-geometric numerical methods, investigation of the method stability is an important task which guarantees the validity of techniques. Without considering the convergence and error analysis, results may lead to solutions with no physical meaning or high-level of errors. This issue may arise from that, we do not know information about the geometric structure of original problem. However, in this paper we introduce a GL(4,R) method which conserve the geometrical properties of problem. Preserving the geometry construction under discretization, is essential in the improvement of a qualitatively true performance in the minimization of approximation errors.
We emphasize that the stepping approach developed for integrating the IVP needs the initial values f1(0)=f(0), f2(0)=f′(0), f3(0)=f″(0) and f4(0)=f‴(0) for the fourth-order ODEs. Both of the last initial values in Eq (2.8) are unknown. Therefore, approximating f″(0) and f‴(0) converts Eq (2.8) into an IVP. It is worth pointing out that every IVP can be integrated by GPS.
Indeed, our proposed method in this paper is split into two parts. In the first part, initial conditions of the problem are obtain by the GL(4,R) method. Our method is implemented by the convergence criterion of (3.26) with ϵ=10−8. For this value of convergence criterion, only four or five steps of algorithm, mentioned in the Appendix, are needed. So, very fast convergence occur in this part of the proposed method Second part of this technique starts when we obtain the initial values of BVP from the first part. Second part which is nominated as the GPS, is an explicit iteration method which is well-known as the weighted Euler method. Convergence of this part can be guaranteed from the geometric structure of method.
The results of this paper were announced with η∞=7 and Δξ=0.01 for the GPS procedure. There is no loss of generality in assuming y03=y04=yf1=yf4=1 as initial guesses.
Some mis-matching errors with various M, C, s, K and χ are plotted in Figure 2(a)-(d). Desired values of r=0.5314, r=0.4993, r=0.814 and r=0.9546 are noticeable from these figures.
In Figure 3(a)-(d), we plot the profiles of f(ξ), f′(ξ), f″(ξ) and f‴(ξ) for various values of magnetic parameter (the Hartmann number) M (√M), and fixed values of the other parameters. It is observable that the profiles of f(ξ) and f′(ξ) decrease, when the magnetic parameter increases, while the reverse situation occur for f″(ξ) and it decrease more rapidly toward zero as ξ tends to η∞.
Figure 4(a)-(d) show the absorbing dependence of the solutions on the various viscoelastic parameter K. Uniform decrease in the magnitudes of f(ξ) and f′(ξ) are observable for increasing values in K. Inverse results occur for the profiles of f(ξ) and f′(ξ) when χ is greater than the boundary value C; see Figure 5(a)-(d). Notice that the plots are in a good agreement with the boundary conditions f′(η∞)=C and f″(η∞)=0.
It may be seen from Figure 6(a)-(d) that for fixed values of K,s,M and χ, the transverse velocity increases with increase in the stagnation point flow C. Notice the behavior of solutions in the profiles of f(ξ), f′(ξ) and f″(ξ) for different cases χ<C and χ>C which are against to the profile of f‴(ξ).
From the Figure 7(a)-(d), an increase in the stretching sheet parameter χ results in a increase in the profiles of f(ξ), f′(ξ) and f‴(ξ). Also, an increase in χ consequences in a decrease in the magnitude of the shear stress at the wall, f″(0).
The double mesh principle is applied to estimate the error
eN(ξ)=|fN(ξ)−f2N(ξ)|, | (4.1) |
where N is the number of GPS iterations. Residual errors of the present method applied for Eq (2.8) with N=10000 are plotted in Figure 8 for various parameters of equation. This figure shows that our method is reliable for current types of equations. Besides, obtained solutions and results are in good agreement with the results of [7].
In this paper, a novel iterative technique based on the Lie group of GL(4,R), as the first time, is proposed to solve the hydromagnetic stagnation point flow of a second grade fluid over a stretching sheet. Structures of the Lie group elements in GL(4,R) and corresponding Lie algebra elements in gl(4,R) are completely innovative for the underlying problem in this paper. Against the non-geometric numerical techniques, the proposed method uses the geometric structure of original problem and this guarantees that obtained results are reliable and the proposed method avoid the ghost solutions. Effects of equation parameters are graphically considered. Point-wise errors for various parameters show the power and effectiveness of proposed method.
No potential competing interest was reported by the authors.
Algorithm of finding initial values of the problem:
(i) Take arbitrary initial guesses for y03, y04, yf1 and yf4.
(ii) Specify an r∈[0,1] and a small ϵ∈R+.
(iii) Calculate G(r) and ω from (3.22) and (3.23), respectively.
(iv) Compute updated values of y03, y04, yf1 and yf4 from (3.25).
(v) If convergence criterion (3.26) is valid for given ϵ, then y03 and y04 are desired initial values of the problem. Otherwise, go to Step (ii).
[1] | Storm HH, Michelsen EV, Clemmensen IH, et al. (1997) The Danish Cancer Registry—history, content, quality and use. Dan Med Bull 44: 535-538. |
[2] |
Vieira CMP, Fragoso M, Ferreira M, et al. (2019) The history of cancer pain and bone-targeted agents: 10 most commonly asked questions. Cancer Manag Res 11: 37. doi: 10.2147/CMAR.S174731
![]() |
[3] |
Taylor AM, Shih J, Ha G, et al. (2018) Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33: 676-689. doi: 10.1016/j.ccell.2018.03.007
![]() |
[4] |
Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432: 316-323. doi: 10.1038/nature03097
![]() |
[5] |
Bredenkamp N, Stirparo GG, Nichols J, et al. (2019) The cell-surface marker Sushi containing domain 2 facilitates establishment of human naive pluripotent stem cells. Stem Cell Rep 12: 1212-1222. doi: 10.1016/j.stemcr.2019.03.014
![]() |
[6] |
Gielen B, Remacle A, Mertens R (2010) Patterns of health care use and expenditure during the last 6 months of life in Belgium: differences between age categories in cancer and non-cancer patients. Health Policy 97: 53-61. doi: 10.1016/j.healthpol.2010.03.002
![]() |
[7] |
Tamargo J, Caballero R, Delpón E (2015) Cancer chemotherapy and cardiac arrhythmias: A review. Drug Saf 38: 129-152. doi: 10.1007/s40264-014-0258-4
![]() |
[8] |
Sui Q, Jiang W, Wu X, et al. (2019) A frameshift mutation in exon 19 of MLH1 in a Chinese Lynch syndrome family: a pedigree study. J Zhejiang Univ Sci B 20: 105. doi: 10.1631/jzus.B1800105
![]() |
[9] |
Lord CJ, Ashworth A (2012) The DNA damage response and cancer therapy. Nature 481: 287-294. doi: 10.1038/nature10760
![]() |
[10] | Alfano RR, Liu CH, Glassman WSMethod for determining if a tissue is a malignant tumor tissue, a benign tumor tissue, or a normal or benign tissue using Raman spectroscopy. U.S. Patent (1993) . |
[11] |
Boldrini R, De Pasquale MD, Melaiu O, et al. (2019) Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors. OncoImmunology 8: e1542245. doi: 10.1080/2162402X.2018.1542245
![]() |
[12] |
Hughes-Parry HE, Cross RS, Jenkins MR (2020) The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells. Int J Mol Sci 21: 204. doi: 10.3390/ijms21010204
![]() |
[13] |
Mirzaei HR, Pourghadamyari H, Rahmati M, et al. (2018) Gene-knocked out chimeric antigen receptor (CAR) T cells: tuning up for the next generation cancer immunotherapy. Cancer Lett 423: 95-104. doi: 10.1016/j.canlet.2018.03.010
![]() |
[14] |
Wicha MS, Liu S, Dontu G (2006) Cancer stem cells: an old idea—a paradigm shift. Cancer Res 66: 1883-1890. doi: 10.1158/0008-5472.CAN-05-3153
![]() |
[15] | Guilford FT, Yu S (2019) Antiparasitic and antifungal medications for targeting cancer cells literature review and case studies. Synth 9: 11. |
[16] | Elinder CG, Kjellstrom T (2019) Carcinogenic and genetic effects. Cadmium and Health: A Toxicological and Epidemiological Appraisal: Volume 2: Effects and Response Boca Raton: CRC Press, 35. |
[17] | Ernst E (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer Interdiscipl Int J Am Cancer Soc 83: 777-782. |
[18] |
Chen S, Giannakou A, Wyman S, et al. (2018) Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture. P Natl Acad Sci Usa 115: E11671-E11680. doi: 10.1073/pnas.1803718115
![]() |
[19] |
Couzin-Frankel J (2013) Cancer immunotherapy. Science 342: 1432-1433. doi: 10.1126/science.342.6165.1432
![]() |
[20] |
Bystrom LM, Rivella S (2015) Cancer cells with irons in the fire. Free Radical Bio Med 79: 337-342. doi: 10.1016/j.freeradbiomed.2014.04.035
![]() |
[21] | Saleh KK, Kakey ES (2018) Some molecular characterization of β-thalassemia major in Koya City. International Conference on Pure and Applied Sciences 4: 64-68. |
[22] |
Kershaw MH, Westwood JA, Parker LL, et al. (2006) A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer. Clin Cancer Res 12: 6106-6115. doi: 10.1158/1078-0432.CCR-06-1183
![]() |
[23] |
Vaissière T, Sawan C, Herceg Z (2008) Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res-Rev Mutat 659: 40-48. doi: 10.1016/j.mrrev.2008.02.004
![]() |
[24] |
Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66: 7-30. doi: 10.3322/caac.21332
![]() |
[25] |
Sudhakar A, Boosani CS (2008) Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression. Pharm Res 25: 2731. doi: 10.1007/s11095-008-9634-z
![]() |
[26] | Li WW, Li VW, Hutnik M, et al. (2012) Tumor angiogenesis as a target for dietary cancer prevention. Int J Oncol 2012: 879623. |
[27] |
Kirkpatrick DB (1984) The first primary brain-tumor operation. J Neurosurg 61: 809-813. doi: 10.3171/jns.1984.61.5.0809
![]() |
[28] | Xu FM, Zhang Y, Xu JH, et al. (2017) Operation and tumor metastasis. J Int Onc 44: 376-379. |
[29] |
Sehouli J, Richter R, Braicu EI, et al. (2010) Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients. J Surg Oncol 102: 656-662. doi: 10.1002/jso.21652
![]() |
[30] | Depierre A, Milleron B, Moro-Sibilot D, et al. (2002) Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non–small-cell lung cancer. J Clin Oncol 20: 247-253. |
[31] |
Hentschel B, Oehler W, Strauß D, et al. (2011) Definition of the CTV prostate in CT and MRI by using CT–MRI image fusion in IMRT planning for prostate cancer. Strahlenther Onkol 187: 183-190. doi: 10.1007/s00066-010-2179-1
![]() |
[32] |
Keshavarzi M, Darijani M, Momeni F, et al. (2017) Molecular imaging and oral cancer diagnosis and therapy. J Cell Biochem 118: 3055-3060. doi: 10.1002/jcb.26042
![]() |
[33] | Saadatpour Z, Bjorklund G, Chirumbolo S, et al. (2016) Molecular imaging and cancer gene therapy. Cancer Gene Ther 1-5. |
[34] |
Jafari SH, Saadatpour Z, Salmaninejad A, et al. (2018) Breast cancer diagnosis: Imaging techniques and biochemical markers. J Cell Physiol 233: 5200-5213. doi: 10.1002/jcp.26379
![]() |
[35] |
Chabner BA, Roberts TG (2005) Chemotherapy and the war on cancer. Nat Rev Cancer 5: 65-72. doi: 10.1038/nrc1529
![]() |
[36] |
Thomas A, Teicher BA, Hassan R (2016) Antibody–drug conjugates for cancer therapy. Lancet Oncol 17: e254-e262. doi: 10.1016/S1470-2045(16)30030-4
![]() |
[37] |
Lam JS, Leppert JT, Vemulapalli SN, et al. (2006) Secondary hormonal therapy for advanced prostate cancer. J Urol 175: 27-34. doi: 10.1016/S0022-5347(05)00034-0
![]() |
[38] |
Yan D, Vicini F, Wong J, et al. (1997) Adaptive radiation therapy. Phys Med Biol 42: 123. doi: 10.1088/0031-9155/42/1/008
![]() |
[39] |
Dawson LA, Jaffray DA (2007) Advances in image-guided radiation therapy. J Clin Oncol 25: 938-946. doi: 10.1200/JCO.2006.09.9515
![]() |
[40] |
Mirzaei HR, Sahebkar A, Salehi R, et al. (2016) Boron neutron capture therapy: Moving toward targeted cancer therapy. J Cancer Res Ther 12: 520. doi: 10.4103/0973-1482.176167
![]() |
[41] |
Seifert HS (2018) Above and beyond watson and crick: Guanine quadruplex structures and microbes. Annu Rev Microbiol 72: 49-69. doi: 10.1146/annurev-micro-090817-062629
![]() |
[42] |
Turner KM, Deshpande V, Beyter D, et al. (2017) Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature 543: 122-125. doi: 10.1038/nature21356
![]() |
[43] |
Friedberg EC (2016) A history of the DNA repair and mutagenesis field: The discovery of base excision repair. DNA repair 37: A35-A39. doi: 10.1016/j.dnarep.2015.12.003
![]() |
[44] |
Zhu K, Liu Q, Zhou Y, et al. (2015) Oncogenes and tumor suppressor genes: comparative genomics and network perspectives. BMC genomics 16: S8. doi: 10.1186/1471-2164-16-S7-S8
![]() |
[45] |
Ratcliffe CD, Sahgal P, Parachoniak CA, et al. (2016) Regulation of cell migration and β1 integrin trafficking by the endosomal adaptor GGA3. Traffic 17: 670-688. doi: 10.1111/tra.12390
![]() |
[46] |
Li D, Kang N, Ji J, et al. (2015) BRCA1 regulates transforming growth factor-β (TGF-β1) signaling through Gadd45a by enhancing the protein stability of Smad4. Mol Oncol 9: 1655-1666. doi: 10.1016/j.molonc.2015.05.002
![]() |
[47] |
Bernstein L (2002) Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7: 3-15. doi: 10.1023/A:1015714305420
![]() |
[48] |
Chen X, Duan N, Zhang C, et al. (2016) Survivin and tumorigenesis: molecular mechanisms and therapeutic strategies. J Cancer 7: 314. doi: 10.7150/jca.13332
![]() |
[49] |
Fodde R (2002) The APC gene in colorectal cancer. Eur J Cancer 38: 867-871. doi: 10.1016/S0959-8049(02)00040-0
![]() |
[50] |
Akavia UD, Litvin O, Kim J, et al. (2010) An integrated approach to uncover drivers of cancer. Cell 143: 1005-1017. doi: 10.1016/j.cell.2010.11.013
![]() |
[51] |
Mirzaei H, Sahebkar A, Sichani LS, et al. (2018) Therapeutic application of multipotent stem cells. J Cell Physiol 233: 2815-2823. doi: 10.1002/jcp.25990
![]() |
[52] |
West NR, McCuaig S, Franchini F, et al. (2015) Emerging cytokine networks in colorectal cancer. Nat Rev Immunol 15: 615-629. doi: 10.1038/nri3896
![]() |
[53] |
Lu J, Wu J, Tian J, et al. (2018) Role of T cell-derived exosomes in immunoregulation. Immunol Res 66: 313-322. doi: 10.1007/s12026-018-9000-0
![]() |
[54] |
Born W, White J, O'Brien R, et al. (1988) Development of T cell receptor expression: studies using T cell hybridomas. Immunol Res 7: 279-291. doi: 10.1007/BF02935533
![]() |
[55] |
Mirzaei H, Salehi H, Oskuee RK, et al. (2018) The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model. Cancer Lett 419: 30-39. doi: 10.1016/j.canlet.2018.01.029
![]() |
[56] |
Zhao L, Cao YJ (2019) Engineered T Cell Therapy for Cancer in the Clinic. Front Immunol 10: 2250. doi: 10.3389/fimmu.2019.02250
![]() |
[57] |
Schlessinger J, Ullrich A (1992) Growth factor signaling by receptor tyrosine kinases. Neuron 9: 383-391. doi: 10.1016/0896-6273(92)90177-F
![]() |
[58] |
Iwamoto M, Saso W, Sugiyama R, et al. (2019) Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization. P Natl Acad Sci Usa 116: 8487-8492. doi: 10.1073/pnas.1811064116
![]() |
[59] |
Moradian Tehrani R, Verdi J, Noureddini M, et al. (2018) Mesenchymal stem cells: a new platform for targeting suicide genes in cancer. J Cell Physiol 233: 3831-3845. doi: 10.1002/jcp.26094
![]() |
[60] |
Mirzaei H, Sahebkar A, Avan A, et al. (2016) Application of mesenchymal stem cells in melanoma: a potential therapeutic strategy for delivery of targeted agents. Curr Med Chem 23: 455-463. doi: 10.2174/0929867323666151217122033
![]() |
[61] |
Pichlmair A, Schulz O, Tan CP, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 997-1001. doi: 10.1126/science.1132998
![]() |
[62] | Grossman JD, Grossman W (2019) Angiogenesis. Rev Cardiovasc Med 3: 138-144. |
[63] |
Hashemi Goradel N, Ghiyami-Hour F, Jahangiri S, et al. (2018) Nanoparticles as new tools for inhibition of cancer angiogenesis. J Cell Physiol 233: 2902-2910. doi: 10.1002/jcp.26029
![]() |
[64] |
Ning S, Laird D, Cherrington JM, et al. (2002) The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation. Radiat Res 157: 45-51. doi: 10.1667/0033-7587(2002)157[0045:TAASAS]2.0.CO;2
![]() |
[65] |
Ye W (2016) The complexity of translating anti-angiogenesis therapy from basic science to the clinic. Dev Cell 37: 114-125. doi: 10.1016/j.devcel.2016.03.015
![]() |
[66] | Sudhakar A (2009) History of Cancer, Ancient and Modern Treatment Methods. J Cancer Res Sci Ther 1: 1-4. |
[67] |
Wood AK, Sehgal CM (2015) A review of low-intensity ultrasound for cancer therapy. Ultrasound Med Biol 41: 905-928. doi: 10.1016/j.ultrasmedbio.2014.11.019
![]() |
[68] |
Romero P, Banchereau J, Bhardwaj N, et al. (2016) The Human Vaccines Project: A roadmap for cancer vaccine development. Sci Transl Med 8: 334ps339-334ps339. doi: 10.1126/scitranslmed.aaf0685
![]() |
[69] |
Paez JG, Jänne PA, Lee JC, et al. (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500. doi: 10.1126/science.1099314
![]() |
[70] |
Zeitoun G, Sissy C, Kirilovsky A, et al. (2019) The immunoscore in the clinical practice of patients with colon and rectal cancers. Chirurgia (Bucur) 114: 152-161. doi: 10.21614/chirurgia.114.2.152
![]() |
[71] |
Fridman WH, Pagès F, Sautes-Fridman C, et al. (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12: 298-306. doi: 10.1038/nrc3245
![]() |
[72] | Rodríguez PC, Rodríguez G, González G, et al. (2010) Clinical development and perspectives of CIMAvax EGF, Cuban vaccine for non-small-cell lung cancer therapy. MEDICC Rev 12: 17-23. |
[73] |
Perez CA, Santos ES, Raez LE (2011) Active immunotherapy for non-small-cell lung cancer: moving toward a reality. Expert Rev Anticancer Ther 11: 1599-1605. doi: 10.1586/era.11.155
![]() |
[74] |
Gattinoni L, Powell DJ, Rosenberg SA, et al. (2006) Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 6: 383-393. doi: 10.1038/nri1842
![]() |
[75] |
Mahoney KM, Rennert PD, Freeman GJ (2015) Combination cancer immunotherapy and new immunomodulatory targets. Nat Rev Drug Discov 14: 561-584. doi: 10.1038/nrd4591
![]() |
[76] |
Restifo NP, Dudley ME, Rosenberg SA (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12: 269-281. doi: 10.1038/nri3191
![]() |
[77] |
Mirzaei HR, Mirzaei H, Lee SY, et al. (2016) Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy. Cancer Lett 380: 413-423. doi: 10.1016/j.canlet.2016.07.001
![]() |
[78] | Han X, Wang Y, Han WD (2018) Chimeric antigen receptor modified T-cells for cancer treatment. Chronic Dis Transl Med 4: 225-243. |
[79] |
Weng J, Lai P, Qin L, et al. (2018) A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia. J Hematol Oncol 11: 25. doi: 10.1186/s13045-018-0572-x
![]() |
[80] |
Turtle CJ, Hanafi LA, Berger C, et al. (2016) CD19 CAR–T cells of defined CD4+: CD8+ composition in adult B cell ALL patients. J Clin Invest 126: 2123-2138. doi: 10.1172/JCI85309
![]() |
[81] |
Wang Y, Zhang W, Han Q, et al. (2014) Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells. Clin Immunol 155: 160-175. doi: 10.1016/j.clim.2014.10.002
![]() |
[82] |
Fry TJ, Shah NN, Orentas RJ, et al. (2018) CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med 24: 20. doi: 10.1038/nm.4441
![]() |
[83] |
Ramos CA, Ballard B, Zhang H, et al. (2017) Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes. J Clin Invest 127: 3462-3471. doi: 10.1172/JCI94306
![]() |
[84] |
Levine BL, Miskin J, Wonnacott K, et al. (2017) Global Manufacturing of CAR T Cell Therapy. Mol Ther-Meth Clin D 4: 92-101. doi: 10.1016/j.omtm.2016.12.006
![]() |
[85] |
Mirzaei HR, Mirzaei H, Namdar A, et al. (2019) Predictive and therapeutic biomarkers in chimeric antigen receptor T-cell therapy: A clinical perspective. J Cell Physiol 234: 5827-5841. doi: 10.1002/jcp.27519
![]() |
[86] |
Newick K, O'Brien S, Moon E, et al. (2017) CAR T cell therapy for solid tumors. Annu Rev Med 68: 139-152. doi: 10.1146/annurev-med-062315-120245
![]() |
[87] |
Eshhar Z (2008) The T-body approach: redirecting T cells with antibody specificity. Therapeutic Antibodies Heidelberg: Springer, 329-342. doi: 10.1007/978-3-540-73259-4_14
![]() |
[88] |
Curran KJ, Pegram HJ, Brentjens RJ (2012) Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions. J Gene Med 14: 405-415. doi: 10.1002/jgm.2604
![]() |
[89] |
Del Nagro CJ, Otero DC, Anzelon AN, et al. (2005) CD 19 function in central and peripheral B-cell development. Immunol Res 31: 119-131. doi: 10.1385/IR:31:2:119
![]() |
[90] |
Mirzaei HR, Jamali A, Jafarzadeh L, et al. (2019) Construction and functional characterization of a fully human anti-CD19 chimeric antigen receptor (huCAR)-expressing primary human T cells. J Cell Physiol 234: 9207-9215. doi: 10.1002/jcp.27599
![]() |
[91] |
Feng K, Guo Y, Dai H, et al. (2016) Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer. Sci China Life Sci 59: 468-479. doi: 10.1007/s11427-016-5023-8
![]() |
[92] |
O'Rourke DM, Nasrallah MP, Desai A, et al. (2017) A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Sci Transl Med 9: eaaa0984. doi: 10.1126/scitranslmed.aaa0984
![]() |
[93] |
Lamers CH, Sleijfer S, Van Steenbergen S, et al. (2013) Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity. Mol Ther 21: 904-912. doi: 10.1038/mt.2013.17
![]() |
[94] |
Thistlethwaite FC, Gilham DE, Guest RD, et al. (2017) The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity. Cancer Immunol Immun 66: 1425-1436. doi: 10.1007/s00262-017-2034-7
![]() |
[95] |
Savoldo B, Ramos CA, Liu E, et al. (2011) CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients. J Clin Invest 121: 1822-1826. doi: 10.1172/JCI46110
![]() |
[96] |
Hartmann J, Schüßler-Lenz M, Bondanza A, et al. (2017) Clinical development of CAR T cells—challenges and opportunities in translating innovative treatment concepts. EMBO Mol Med 9: 1183-1197. doi: 10.15252/emmm.201607485
![]() |
[97] |
Srivastava S, Riddell SR (2015) Engineering CAR-T cells: design concepts. Trends Immunol 36: 494-502. doi: 10.1016/j.it.2015.06.004
![]() |
[98] |
Linehan DC, Goedegebuure PS (2005) CD25+ CD4+ regulatory T-cells in cancer. Immunol Res 32: 155-168. doi: 10.1385/IR:32:1-3:155
![]() |
[99] | Frey NV, Porter DL (2016) The promise of chimeric antigen receptor T-cell therapy. Oncology-Basel 30. |
[100] |
Maude SL, Frey N, Shaw PA, et al. (2014) Chimeric antigen receptor T cells for sustained remissions in leukemia. New Engl J Med 371: 1507-1517. doi: 10.1056/NEJMoa1407222
![]() |
[101] |
Turtle CJ, Berger C, Sommermeyer D, et al. (2015) Anti-CD19 chimeric antigen receptor-modified T cell therapy for B cell non-Hodgkin lymphoma and chronic lymphocytic leukemia: fludarabine and cyclophosphamide lymphodepletion improves in vivo expansion and persistence of CAR-T cells and clinical outcomes. Blood 126: 184. doi: 10.1182/blood.V126.23.184.184
![]() |
[102] |
Zhao Z, Chen Y, Francisco NM, et al. (2018) The application of CAR-T cell therapy in hematological malignancies: advantages and challenges. Acta Pharm Sin B 8: 539-551. doi: 10.1016/j.apsb.2018.03.001
![]() |
[103] |
Carpenter RO, Evbuomwan MO, Pittaluga S, et al. (2013) B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Clin Cancer Res 19: 2048-2060. doi: 10.1158/1078-0432.CCR-12-2422
![]() |
1. | Shoukry El‐Ganaini, Hitender Kumar, A variety of new soliton structures and various dynamical behaviors of a discrete electrical lattice with nonlinear dispersion via variety of analytical architectures, 2023, 46, 0170-4214, 2746, 10.1002/mma.8673 | |
2. | Muhammad Imran Asjad, Naeem Ullah, Asma Taskeen, Fahd Jarad, Study of power law non-linearity in solitonic solutions using extended hyperbolic function method, 2022, 7, 2473-6988, 18603, 10.3934/math.20221023 | |
3. | Shahram Rezapour, Muhammad Imran Liaqat, Sina Etemad, Kolade M. Owolabi, An Effective New Iterative Method to Solve Conformable Cauchy Reaction-Diffusion Equation via the Shehu Transform, 2022, 2022, 2314-4785, 1, 10.1155/2022/4172218 | |
4. | Erdoğan Mehmet Özkan, Mutlu Akar, Analytical solutions of (2+1)-dimensional time conformable Schrödinger equation using improved sub-equation method, 2022, 267, 00304026, 169660, 10.1016/j.ijleo.2022.169660 | |
5. | Sakda Noinang, Zulqurnain Sabir, Shumaila Javeed, Muhammad Asif Zahoor Raja, Dostdar Ali, Wajaree Weera, Thongchai Botmart, A Novel Stochastic Framework for the MHD Generator in Ocean, 2022, 73, 1546-2226, 3383, 10.32604/cmc.2022.029166 | |
6. | Mohamed S. Mohamed, Lanre Akinyemi, S. A. Najati, S. K. Elagan, Abundant solitary wave solutions of the Chen–Lee–Liu equation via a novel analytical technique, 2022, 54, 0306-8919, 10.1007/s11082-022-03535-9 | |
7. | Erdogan Mehmet Ozkan, New Exact Solutions of Some Important Nonlinear Fractional Partial Differential Equations with Beta Derivative, 2022, 6, 2504-3110, 173, 10.3390/fractalfract6030173 | |
8. | Renfei Luo, Neeraj Dhiman, Fakhroddin Nazari, Jamilu Sabi'u, Hijaz Ahmad, Phatiphat Thounthong, Thongchai Botmart, On new explicit solutions for solving Atangana conformable Biswas-Milovic equation with parabolic law nonlinearity in nonlinear optics, 2022, 40, 22113797, 105760, 10.1016/j.rinp.2022.105760 | |
9. | Hassan Almusawa, Lie symmetry analysis and conservation laws of two-mode Cahn-Allen equation, 2022, 179, 03930440, 104579, 10.1016/j.geomphys.2022.104579 | |
10. | Umme Sadiya, Mustafa Inc, Mohammad Asif Arefin, M. Hafiz Uddin, Consistent travelling waves solutions to the non-linear time fractional Klein–Gordon and Sine-Gordon equations through extended tanh-function approach, 2022, 16, 1658-3655, 594, 10.1080/16583655.2022.2089396 | |
11. | THILAGARAJAH MATHANARANJAN, DAYALINI VIJAYAKUMAR, NEW SOLITON SOLUTIONS IN NANO-FIBERS WITH SPACE-TIME FRACTIONAL DERIVATIVES, 2022, 30, 0218-348X, 10.1142/S0218348X22501419 | |
12. | Hassan Almusawa, Adil Jhangeer, Nonlinear self-adjointness, conserved quantities and Lie symmetry of dust size distribution on a shock wave in quantum dusty plasma, 2022, 114, 10075704, 106660, 10.1016/j.cnsns.2022.106660 | |
13. | Ayten Özkan, A view of solitary wave solutions to the fractional DNA Peyrard-Bishop equation via a new approach, 2024, 99, 0031-8949, 055269, 10.1088/1402-4896/ad3e32 | |
14. | Ayten Özkan, Erdoĝan Mehmet Özkan, A study of novel optical solutions of the space-time fractional cubic nonlinear Schrödinger equation, 2024, 56, 0306-8919, 10.1007/s11082-023-05779-5 | |
15. | Erdogan Mehmet Ozkan, Ozgur Yildirim, Ayten Ozkan, On the exact solutions of optical perturbed fractional Schrödinger equation, 2023, 98, 0031-8949, 115104, 10.1088/1402-4896/acfa2f | |
16. | Thilagarajah Mathanaranjan, 2024, 9780443154041, 155, 10.1016/B978-0-44-315404-1.00015-1 | |
17. | Ali Rehman, Ma Chau Khun, Mustafa Inc, Lakhdar Ragoub, Shahram Rezapour, Taseer Muhammad, Analytical analysis of water and engine oil base nanofluid flow with the influence of viscous dissipation and variable viscosity on stretching surface, 2024, 104, 0044-2267, 10.1002/zamm.202300773 | |
18. | Umair Asghar, Muhammad Imran Asjad, Waqas Ali Faridi, Ali Akgül, Novel solitonic structure, Hamiltonian dynamics and lie symmetry algebra of biofilm, 2024, 9, 26668181, 100653, 10.1016/j.padiff.2024.100653 | |
19. | Aneesa Nadeem, Sami Ullah Khan, Yasir Khan, Mehdi Akermi, Rim Hassani, Features of hydrocarbon liquid-based nanofluid under augmentation of parametric ranges in non-Darcy media, 2024, 0217-9849, 10.1142/S0217984925500411 | |
20. | Waseem Abbas, A. M. Obalalu, Yasir Khan, Mehdi Akermi, Rim Hassani, Thermal characteristics of nanofluid through a convective surface under influential heating source and temperature slip, 2024, 0217-9849, 10.1142/S0217984925500782 | |
21. | Muhammad Jawaz, Jorge E. Macías-Díaz, Syed A. Aqeel, Nauman Ahmed, Muhammad Z. Baber, María G. Medina-Guevara, On some explicit solitary wave patterns for a generalized nonlinear reaction–diffusion equation with conformable temporal fractional derivative, 2025, 13, 26668181, 101036, 10.1016/j.padiff.2024.101036 |